Chargement en cours...
Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
Recombinant human erythropoietin (rHuEPO) has been advocated for the treatment of anaemia in patients submitted to cancer chemotherapy. We used decision analysis to compare the cost-effectiveness of rHuEPO supplemented with red blood cell (RBC) transfusions with conventional treatment with RBC trans...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group|1
1998
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2062982/ https://ncbi.nlm.nih.gov/pubmed/9743301 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|